Smoking-associated gene expression alterations in nasal epithelium reveal immune impairment linked to lung cancer risk.

Our results provide initial evidence for germline-mediated personalized smoke injury response and risk in the general population, with potential implications for managing long-term lung cancer incidence and mortality.